Related Experiment Videos
Ischemic cardiovascular complications concurrent with administration of captopril. A clinical note
Insights
Potent blood pressure lowering drugs like captopril can trigger heart attacks in coronary artery disease patients. This risk increases if beta-blockers like propranolol are stopped before starting these new medications.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Coronary artery disease (CAD) management often involves beta-blockers and angiotensin-converting enzyme (ACE) inhibitors.
- ACE inhibitors, such as captopril, are potent vasodepressors.
- Beta-blocking drugs, like propranolol, are commonly used for cardiovascular protection.
Observation:
- Administration of ACE inhibitors can precipitate myocardial ischemic events in patients with CAD.
- This risk is particularly pronounced when ACE inhibitor treatment follows the discontinuation of beta-blockers.
Findings:
- A patient on captopril after stopping propranolol experienced three episodes of angina pectoris.
- Another patient exhibited symptoms suggestive of acute anterior myocardial infarction under similar circumstances.
Implications:
- Clinicians should exercise caution when initiating ACE inhibitors in patients with CAD, especially those recently withdrawn from beta-blockers.
- Careful monitoring for myocardial ischemia is warranted during such treatment transitions.
- Understanding drug interactions is crucial for preventing adverse cardiovascular events in high-risk patients.
Abstract:
Administration of potent vasodepressor agents such as the angiotensin converting enzyme inhibitor, captopril, may precipitate myocardial ischemic events in patients with coronary artery disease, particularly if this treatment is preceded by a discontinuation of beta-blocking drugs such as propranolol. In one case studied, a patient experienced three episodes of angina pectoris under these conditions; in another, acute anterior myocardial infarction was suspect.